Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Adem Kidik"'
Autor:
Berna Bozkurt DUMAN, Berksoy ŞAHİN, Oğuz İsmail KARA, Melek ERKİŞİ, Adem KIDIK, Melek ERGİN, Emine Kılıç BAĞIR
Publikováno v:
Cukurova Medical Journal, Vol 39, Iss 1, Pp 53-60 (2014)
Amaç: HER-2"nin değerlendirilmesi, HER-2 antikor tedavisinin takibinde büyük öneme sahiptir. Transtuzumab tedavisinde HER-2"nin değerlendirilmesi protein aşırı üretiminin standart immünohistokimyasal yöntemler ile veya gen amplifikasyonun
Externí odkaz:
https://doaj.org/article/91ae969060644eb08d2c2237b1ab48de
Autor:
Berna Bozkurt Duman, Berksoy Sahin, Oguz Ismail Kara, Melek Erkisi, Adem Kidik, Melek Ergin, Emine Kilic Bagir
Publikováno v:
Çukurova Üniversitesi Tıp Fakültesi Dergisi, Vol 39, Iss 1, Pp 53-60 (2014)
Purpose: Assessment of HER-2 has become of great importance following the advent of HER-2 antibody treatment. Use of trastuzumab therapy depends on the assessment of HER-2 via standard immunohistochemistry (IHC) assays for protein overexpression or v
Externí odkaz:
https://doaj.org/article/2c838e4b4bff45899d22ff899dc60a80
Publikováno v:
Annals of Hepatology, Vol 11, Iss 4, Pp 513-518 (2012)
Introduction. The use of prognostic models for cirrhotic patients admitted to the medical intensive care unit (ICU) is of great importance, since they provide an objective evaluation for a group of patients with high mortality rates and high resource
Externí odkaz:
https://doaj.org/article/cd23d09ff54c4de1b7e6f96a1737c3c7
Publikováno v:
Annals of Hepatology, Vol 11, Iss 4, Pp 513-518 (2012)
Introduction. The use of prognostic models for cirrhotic patients admitted to the medical intensive care unit (ICU) is of great importance, since they provide an objective evaluation for a group of patients with high mortality rates and high resource
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::242ed4f388dd85247aaa1e5357295b66
https://pubmed.ncbi.nlm.nih.gov/22700633
https://pubmed.ncbi.nlm.nih.gov/22700633